about
Rare presentation of Ewing sarcoma metastasis to the sella and suprasellar cistern.Dynamic Contrast-Enhanced MRI in Low-Grade Versus Anaplastic Oligodendrogliomas.Repeatability Investigation of Reduced Field-of-View Diffusion-Weighted Magnetic Resonance Imaging on Thyroid Glands.Using diffusion-weighted MRI to predict aggressive histological features in papillary thyroid carcinoma: a novel tool for pre-operative risk stratification in thyroid cancerNonenhancing Leptomeningeal Metastases: Imaging Characteristics and Potential Causative FactorsHypertrophic olivary degeneration resulting from posterior fossa masses and their treatments.A prospective trial of dynamic contrast-enhanced MRI perfusion and fluorine-18 FDG PET-CT in differentiating brain tumor progression from radiation injury after cranial irradiation.Nonalcoholic Thiamine-Related Encephalopathy (Wernicke-Korsakoff Syndrome) Among Inpatients With Cancer: A Series of 18 Cases.Palliative treatment of thiamine-related encephalopathy (Wernicke's encephalopathy) in cancer: A case series and review of the literature.Comparison of the effectiveness of MRI perfusion and fluorine-18 FDG PET-CT for differentiating radiation injury from viable brain tumor: a preliminary retrospective analysis with pathologic correlation in all patientsMultimodality functional imaging using DW-MRI and 18F-FDG-PET/CT during radiation therapy for human papillomavirus negative head and neck squamous cell carcinoma: Meixoeiro Hospital of Vigo Experience.Weekly response assessment of involved lymph nodes to radiotherapy using diffusion-weighted MRI in oropharynx squamous cell carcinoma.Intravoxel incoherent motion diffusion-weighted MRI during chemoradiation therapy to characterize and monitor treatment response in human papillomavirus head and neck squamous cell carcinoma.Dynamic contrast-enhanced MRI perfusion for differentiating between melanoma and lung cancer brain metastases.West Nile Virus Central Nervous System Infection in Patients Treated With Rituximab: Implications for Diagnosis and Prognosis, With a Review of Literature.Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma.MR findings of fibrodysplasia ossificans progressiva complicated by acute cord compression: Case report and literature review.Toxoplasma Encephalitis in Atypical Hosts at an Academic Cancer Center.Diagnostic Accuracy of T1-Weighted Dynamic Contrast-Enhanced-MRI and DWI-ADC for Differentiation of Glioblastoma and Primary CNS Lymphoma.Ribosomal RNA gene sequencing for early diagnosis of Blastomyces dermatitidis infection.Second-opinion interpretations of neuroimaging studies by oncologic neuroradiologists can help reduce errors in cancer care.Diffuse reduction of cerebral grey matter volumes in Erdheim-Chester disease.Temporal lobe meningioma with ipsilateral herpes simplex encephalitisPost-treatment T1 shortening in primary CNS lymphoma.Early Post-treatment Assessment of MRI Perfusion Biomarkers Can Predict Long-term Response of Lung Cancer Brain Metastases to Stereotactic Radiosurgery."Comment on Hatzoglou et al.: Dynamic contrast-enhanced MRI perfusion vs 18FDG PET/CT in differentiating brain tumor progression from radiation injury"-Reply.A Magnetic Resonance Imaging-based approach to quantify radiation-induced normal tissue injuries applied to trismus in head and neck cancer.Pretreatment dynamic contrast-enhanced MRI biomarkers correlate with progression-free survival in primary central nervous system lymphomaResting-State Functional Connectivity of the Middle Frontal Gyrus Can Predict Language Lateralization in Patients with Brain TumorsIdentification of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer by Using HER2-targeted 89Zr-Pertuzumab PET/CT
P50
Q31141120-98B8647B-8109-4531-BB3D-7241DC4CBB59Q33904348-147E102C-18F5-4E83-9619-1253DB746F4DQ35611375-C29276D1-3F04-45F6-9E85-BBD42DC77357Q35814446-257D4CEF-3632-439A-A432-96CF5A7BCAF3Q36376178-1C547EE6-6C97-48AB-A236-4A726751576EQ36578560-BC9AF3F9-91A8-4A83-B237-E50531D75418Q36893250-9E9D751C-F054-48B8-A5E6-FCA5FBC65CA8Q37165409-E9C99DD0-77BC-4052-A851-6461EAD8DD28Q37170831-7C574EE6-1F37-46FA-AE0F-617B837F16E0Q37212449-5F0A02B9-4DAD-4FA6-8FF4-95673006D5EBQ37590957-6BBCC0FA-869C-4D3C-ABE2-4F6C82863DBAQ37713795-09C07CDF-D456-4C33-9E0E-DA39399E796EQ37717953-21EACDB9-22A9-4453-93E1-13CC71D32678Q37747457-6793E92E-D8A4-42A3-922B-ACA4244D2817Q38635750-2536247F-85D2-46E3-8E76-D9D3001E7A5EQ38723290-5CB6DED5-A060-4889-B085-D006E3B08A90Q38866585-26726091-B9CB-4BA4-9535-ABA2967CF5D0Q40280329-F7C53C10-E087-4598-BEED-818FA3938119Q40433973-9DEEA6FA-BD2D-439C-AC93-7FC05E2F9C50Q41130209-D3745C52-7BF0-4D6B-8E3B-048C8B9DF7E1Q41492757-367D933A-BA70-4672-8DEA-16B7F31CCC4AQ42383661-0DD83F22-DA1E-4112-9A67-62C0C875BE91Q42782321-2A000405-E044-476A-A50F-3746D4B5FC69Q44437452-8A5A6E1B-B24B-41D6-AD70-1D2A07DB620BQ47827501-F2E7738A-B9C9-424B-93D4-F503ED12D190Q48376154-FBC9A643-4804-4973-BFD9-7626013D4D77Q52923469-F0931523-FFA6-4796-A70C-789D4C04B62EQ90730534-FF52C38C-9AFF-4491-B492-84C876ED832AQ90988532-9C5606EC-A3EE-42FF-8397-DF289C6721EBQ96222104-D881781E-58FF-4888-ACE8-EE3939AD4413
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Vaios Hatzoglou
@ast
Vaios Hatzoglou
@en
Vaios Hatzoglou
@es
Vaios Hatzoglou
@nl
Vaios Hatzoglou
@sl
type
label
Vaios Hatzoglou
@ast
Vaios Hatzoglou
@en
Vaios Hatzoglou
@es
Vaios Hatzoglou
@nl
Vaios Hatzoglou
@sl
prefLabel
Vaios Hatzoglou
@ast
Vaios Hatzoglou
@en
Vaios Hatzoglou
@es
Vaios Hatzoglou
@nl
Vaios Hatzoglou
@sl
P106
P1153
55387666700
P31
P496
0000-0003-0252-0694